Figure 3
Figure 3. Hemostatic effect of recombinant FVIII variant protein in HA mice. (A) The graph shows the time of full occlusion of the carotid artery upon 7.5% FeCl3–induced injury. HA mice (C57BL/6) received 20 μg/kg of FVIII-RH (n = 5), FVIII-BDD (n = 4), or phosphate-buffered saline (PBS) (n = 3). (B) Blood loss following tail clipping is shown in the graph. HA mice (C57BL6/129Sv) received tail vein injection of FVIII-RH or FVIII-BDD at doses indicated or PBS (n = 5 mice per group). Hemostatically normal mice (n = 3, C57BL/6) were used as normal controls. Total blood loss (μL) was measured after tail transection at a 3-mm diameter, and blood was collected for 10 minutes. n.s., not significant.

Hemostatic effect of recombinant FVIII variant protein in HA mice. (A) The graph shows the time of full occlusion of the carotid artery upon 7.5% FeCl3–induced injury. HA mice (C57BL/6) received 20 μg/kg of FVIII-RH (n = 5), FVIII-BDD (n = 4), or phosphate-buffered saline (PBS) (n = 3). (B) Blood loss following tail clipping is shown in the graph. HA mice (C57BL6/129Sv) received tail vein injection of FVIII-RH or FVIII-BDD at doses indicated or PBS (n = 5 mice per group). Hemostatically normal mice (n = 3, C57BL/6) were used as normal controls. Total blood loss (μL) was measured after tail transection at a 3-mm diameter, and blood was collected for 10 minutes. n.s., not significant.

Close Modal

or Create an Account

Close Modal
Close Modal